Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Cells Studied

HMS LINCS ID Name LINCS ID Alternative ID
50331-1 MDA-MB-361 LCL-1468
50332-2 MDA-MB-415 LCL-1469
50333-1 MDA-MB-436 LCL-1470
50334-1 MDA-MB-453 LCL-1485
50335-1 MDA-MB-468 LCL-1471
50541-1 T47D LCL-1486
50556-1 UACC-812 LCL-1319
50557-1 UACC-893 LCL-1320
50574-1 ZR-75-1 LCL-1321
50576-1 184B5 LCL-2081
50578-1 HCC1187 LCL-1324
50583-1 MCF 10A LCL-2085
50584-1 MCF 10F LCL-2102
51081-1 SUM1315MO2 LCL-2066
51082-1 SUM149PT LCL-2067
51083-1 SUM159PT LCL-2068
51084-1 SUM185PE LCL-2069
51085-1 SUM225CWN LCL-2070
51086-1 SUM229PE LCL-2065
51087-1 SUM52PE LCL-2071
51088-1 184A1 LCL-2080
51089-1 MCF12A LCL-2082
51090-1 MX1 LCL-2072
51091-1 T47DKBLUC LCL-2064
51092-1 600MPE LCL-2073